HIV News Alert

November 13, 2024: The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV have been updated.   Immunizations These guidelines are published in an electronic format and updated as changes in prevention and treatment science occurs. All updates are developed by the subject matter groups listed in Appendix B. Guideline updates are reviewed…

On October 21, 2024, the Departments of Health and Human Services, Labor, and the Treasury (the Departments) issued new guidance. The guidance clarifies that with the United States Preventive Services Task Force’s (USPSTF) 2023 update to its recommendation on the prevention of acquisition of HIV, most health coverage that people receive through their employer, or…

October 11, 2024: The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV have been updated.   Bacterial Enteric Infections  These guidelines are published in an electronic format and updated as changes in prevention and treatment science occurs. All updates are developed by the subject matter groups listed in Appendix B. Guideline updates…

September 30, 2024: HHS Centers for Medicare and Medicaid Services finalized a National Coverage Determination for HIV PrEP — Under this NCD, CMS will cover all forms of PrEP that are approved for use by the FDA for any Medicare recipient (Medicare is coverage for older adults and people with disabilities) at risk for HIV (as determined by the…

September 16, 2024: The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV have been updated.   Candidiasis  Pneumocystis Pneumonia  Toxoplasma gondii Encephalitis  These guidelines are published in an electronic format and updated as changes in prevention and treatment science occurs. All updates are developed by the subject matter groups listed in…

(September 12, 2024): The Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) updated the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV. For a comprehensive list of recent updates, please see What’s New in the Guidelines. The updated Sections are outlined below.  New Section Added to the Guidelines  Sections With Key Updates  Sections…

The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV have been updated.   Mycobacterium avium Complex  These guidelines are published in an electronic format and updated as changes in prevention and treatment science occurs. All updates are developed by the subject matter groups listed in Appendix B. Guideline updates are reviewed…

July 29, 2024: The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV have been updated.   Leishmaniasis -Updated information on prevalence, including transmission in the United States. -Updated information on the use of polymerase chain reaction, or PCR, and serological tests for the diagnosis of leishmanial diseases. -Updated treatment regimens for each of the…

July 9, 2024: The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV have been updated. These updates include new recommendations related to anal cancer screening and treatment.   Human Papillomavirus  These guidelines are published in an electronic format and updated as relevant changes in prevention and treatment recommendations occur. All updates…

June 4, 2024: CDC published clinical guidelines on counseling patients regarding doxycycline post-exposure prophylaxis (or doxy PEP) for bacterial sexually transmitted infection (STI) prevention. Doxy PEP has proven to reduce the risk of getting a bacterial STI for gay, bisexual, and other men who have sex with men and transgender women at increased risk for these…